loader
Please Wait
Applying Filters...

Ofichem Header Ofichem Header

X

Technical details about Mesdopetam, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: Irl790, Irl-790, Hd4qv8gx26, 1403894-72-3, N-[2-(3-fluoro-5-methylsulfonylphenoxy)ethyl]propan-1-amine, 1-propanamine, n-(2-(3-fluoro-5-(methylsulfonyl)phenoxy)ethyl)-
Molecular Formula
C12H18FNO3S
Molecular Weight
275.34  g/mol
InChI Key
OSBPYFBXSLJHCR-UHFFFAOYSA-N
FDA UNII
HD4QV8GX26

Mesdopetam is under investigation in clinical trial NCT04435431 (A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia).
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[2-(3-fluoro-5-methylsulfonylphenoxy)ethyl]propan-1-amine
2.1.2 InChI
InChI=1S/C12H18FNO3S/c1-3-4-14-5-6-17-11-7-10(13)8-12(9-11)18(2,15)16/h7-9,14H,3-6H2,1-2H3
2.1.3 InChI Key
OSBPYFBXSLJHCR-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCNCCOC1=CC(=CC(=C1)S(=O)(=O)C)F
2.2 Other Identifiers
2.2.1 UNII
HD4QV8GX26
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Irl790

2. N-(2-(3-fluoro-5-methylsulfonylphenoxy)ethyl)propan-1-amine

2.3.2 Depositor-Supplied Synonyms

1. Irl790

2. Irl-790

3. Hd4qv8gx26

4. 1403894-72-3

5. N-[2-(3-fluoro-5-methylsulfonylphenoxy)ethyl]propan-1-amine

6. 1-propanamine, N-(2-(3-fluoro-5-(methylsulfonyl)phenoxy)ethyl)-

7. Mesdopetam [inn]

8. Unii-hd4qv8gx26

9. Mesdopetam [who-dd]

10. Chembl4594447

11. Schembl13732678

12. Gtpl10811

13. Hy-109150

14. Cs-0115974

15. N-[2-(3-fluoro-5-methylsulfonyl-phenoxy)ethyl]propan-1-amine

16. N-{2-[3-fluoro-5-(methylsulfonyl)phenoxy]ethyl}-n-propylamine

2.4 Create Date
2013-03-21
3 Chemical and Physical Properties
Molecular Weight 275.34 g/mol
Molecular Formula C12H18FNO3S
XLogP31.7
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count7
Exact Mass275.09914277 g/mol
Monoisotopic Mass275.09914277 g/mol
Topological Polar Surface Area63.8 Ų
Heavy Atom Count18
Formal Charge0
Complexity329
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Dopamine Antagonists

Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)


Post Enquiry
POST ENQUIRY